X-rays-Induced Bystander Effect Consists in the Formation of DNA Breaks in a Calcium-Dependent Manner: Influence of the Experimental Procedure and the Individual Factor.


Journal

Biomolecules
ISSN: 2218-273X
Titre abrégé: Biomolecules
Pays: Switzerland
ID NLM: 101596414

Informations de publication

Date de publication:
16 03 2023
Historique:
received: 24 01 2023
revised: 22 02 2023
accepted: 07 03 2023
medline: 30 3 2023
entrez: 29 3 2023
pubmed: 30 3 2023
Statut: epublish

Résumé

Radiation-induced bystander effects (RIBE) describe the biological events occurring in non-targeted cells in the vicinity of irradiated ones. Various experimental procedures have been used to investigate RIBE. Interestingly, most micro-irradiation experiments have been performed with alpha particles, whereas most medium transfers have been done with X-rays. With their high fluence, synchrotron X-rays represent a real opportunity to study RIBE by applying these two approaches with the same radiation type. The RIBE induced in human fibroblasts by the medium transfer approach resulted in a generation of DNA double-strand breaks (DSB) occurring from 10 min to 4 h post-irradiation. Such RIBE was found to be dependent on dose and on the number of donor cells. The RIBE induced with the micro-irradiation approach produced DSB with the same temporal occurrence. Culture media containing high concentrations of phosphates were found to inhibit RIBE, while media rich in calcium increased it. The contribution of the RIBE to the biological dose was evaluated after synchrotron X-rays, media transfer, micro-irradiation, and 6 MeV photon irradiation mimicking a standard radiotherapy session: the RIBE may represent less than 1%, about 5%, and about 20% of the initial dose, respectively. However, RIBE may result in beneficial or otherwise deleterious effects in surrounding tissues according to their radiosensitivity status and their capacity to release Ca

Identifiants

pubmed: 36979480
pii: biom13030542
doi: 10.3390/biom13030542
pmc: PMC10046354
pii:
doi:

Substances chimiques

Calcium SY7Q814VUP
DNA 9007-49-2

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Radiat Res. 2002 Apr;157(4):365-70
pubmed: 11893237
Mutat Res. 2002 Feb 20;499(2):135-41
pubmed: 11827706
J Cell Sci. 2009 Jul 15;122(Pt 14):2337-50
pubmed: 19571113
Dose Response. 2020 May 8;18(2):1559325820913784
pubmed: 32425719
Int J Radiat Biol. 1990 Jul;58(1):125-31
pubmed: 1973430
Cancer Res. 2002 Oct 1;62(19):5436-42
pubmed: 12359750
Int J Radiat Biol. 1997 Sep;72(3):271-83
pubmed: 9298107
Int J Radiat Biol. 2018 Aug;94(8):696-707
pubmed: 29095061
Mutat Res. 2006 May 11;597(1-2):1-4
pubmed: 16414091
Int J Radiat Biol. 2020 Mar;96(3):394-410
pubmed: 31738647
Cancer Res. 2003 Jun 15;63(12):3221-7
pubmed: 12810651
Biochem J. 1997 Feb 1;321 ( Pt 3):691-8
pubmed: 9032455
EMBO J. 2003 Jun 2;22(11):2860-71
pubmed: 12773400
Cancer Res. 1997 Jun 1;57(11):2164-71
pubmed: 9187116
Int J Radiat Biol. 1997 Apr;71(4):421-7
pubmed: 9154145
Oncotarget. 2015 Apr 30;6(12):10161-74
pubmed: 25868859
Radiat Prot Dosimetry. 2020 Dec 30;192(2):236-252
pubmed: 33395702
Int J Radiat Biol. 2000 Aug;76(8):1025-35
pubmed: 10947115
Radiat Res. 2010 Mar;173(3):380-5
pubmed: 20199223
Phys Med. 2015 Sep;31(6):584-95
pubmed: 25817634
Mol Cell. 1998 Jun;1(7):969-79
pubmed: 9651580
Mol Cell. 2018 Aug 2;71(3):419-427
pubmed: 30057197
Int J Radiat Biol. 2003 Jan;79(1):35-41
pubmed: 12556329
Proc Natl Acad Sci U S A. 2000 Feb 29;97(5):2099-104
pubmed: 10681418
Biochem Biophys Res Commun. 1991 Dec 16;181(2):915-20
pubmed: 1661594
Mutat Res Rev Mutat Res. 2016 Oct - Dec;770(Pt B):369-386
pubmed: 27919342
Radiat Res. 2001 Mar;155(3):397-401
pubmed: 11182789
J Theor Biol. 2013 Sep 21;333:135-45
pubmed: 23735818
Radiat Res. 2006 Apr;165(4):400-9
pubmed: 16579652
Proc Natl Acad Sci U S A. 2001 Jan 16;98(2):473-8
pubmed: 11149936
Int J Radiat Oncol Biol Phys. 2016 Mar 1;94(3):450-60
pubmed: 26867874
Radiat Res. 2006 Sep;166(3):479-87
pubmed: 16953666
Ann Biol Clin (Paris). 1986;44(1):77-87
pubmed: 3706837
PLoS One. 2015 Mar 23;10(3):e0119924
pubmed: 25799425
Oncogene. 2005 Nov 10;24(49):7257-65
pubmed: 16170376
Int J Radiat Biol. 1996 Feb;69(2):241-9
pubmed: 8609461
Int J Mol Sci. 2021 Jul 02;22(13):
pubmed: 34281212
Mol Cell Biol. 2001 Jan;21(1):281-8
pubmed: 11113202
J Synchrotron Radiat. 2011 Jul;18(Pt 4):630-6
pubmed: 21685681
Int J Radiat Biol. 2016;92(3):117-31
pubmed: 26907628
Med Confl Surviv. 2005 Apr-Jun;21(2):101-10
pubmed: 16050242
Br J Cancer. 2000 Nov;83(9):1223-30
pubmed: 11027437
Oncogene. 2007 Feb 15;26(7):993-1002
pubmed: 16909103
Curr Eye Res. 2021 Apr;46(4):546-557
pubmed: 32862699
Nucleic Acids Res. 2004 Mar 05;32(4):1602-9
pubmed: 15004247
Int J Radiat Biol. 2006 Jun;82(6):393-9
pubmed: 16846974
Cancer Res. 2004 Apr 1;64(7):2317-23
pubmed: 15059878
Cancers (Basel). 2019 Aug 23;11(9):
pubmed: 31450803
Cancers (Basel). 2019 Jun 28;11(7):
pubmed: 31261657
J Photochem Photobiol B. 2003 Dec 5;72(1-3):55-60
pubmed: 14644566
Mutat Res. 2004 Dec 2;568(1):41-8
pubmed: 15530538
Radiat Res. 1998 Mar;149(3):256-62
pubmed: 9496888
Cancer Res. 1992 Nov 15;52(22):6394-6
pubmed: 1423287
Radiat Res. 2003 Feb;159(2):262-7
pubmed: 12537532
Int J Radiat Biol. 2013 Jun;89(6):445-53
pubmed: 23363251
Oncogene. 2005 Mar 17;24(12):2096-103
pubmed: 15688009
Int J Mol Sci. 2022 Sep 09;23(18):
pubmed: 36142346
Radiat Res. 1996 Mar;145(3):260-7
pubmed: 8927692
Int J Radiat Oncol Biol Phys. 2008 Apr 1;70(5):1310-8
pubmed: 18374221
Proc Natl Acad Sci U S A. 2003 Apr 29;100(9):5057-62
pubmed: 12679524
Cancer Res. 2000 Mar 1;60(5):1290-8
pubmed: 10728689
Oncogene. 2003 Oct 13;22(45):7050-7
pubmed: 14557810
Plant Sci. 2021 Jan;302:110730
pubmed: 33288030
Mutat Res. 2010 Apr-Jun;704(1-3):160-6
pubmed: 20034592
Proc Natl Acad Sci U S A. 1999 Apr 27;96(9):4959-64
pubmed: 10220401
Int J Radiat Biol. 2009 Jan;85(1):87-95
pubmed: 19205987
J Cell Sci. 2004 Oct 1;117(Pt 21):4935-45
pubmed: 15367581
Nat Rev Cancer. 2004 Feb;4(2):158-64
pubmed: 14964312

Auteurs

Juliette Restier-Verlet (J)

INSERM U1296 unit "Radiation: Defense/Health/Environment" Centre Léon-Bérard, 69008 Lyon, France.

Aurélie Joubert (A)

INSERM U1296 unit "Radiation: Defense/Health/Environment" Centre Léon-Bérard, 69008 Lyon, France.

Mélanie L Ferlazzo (ML)

INSERM U1296 unit "Radiation: Defense/Health/Environment" Centre Léon-Bérard, 69008 Lyon, France.

Adeline Granzotto (A)

INSERM U1296 unit "Radiation: Defense/Health/Environment" Centre Léon-Bérard, 69008 Lyon, France.

Laurène Sonzogni (L)

INSERM U1296 unit "Radiation: Defense/Health/Environment" Centre Léon-Bérard, 69008 Lyon, France.

Joëlle Al-Choboq (J)

INSERM U1296 unit "Radiation: Defense/Health/Environment" Centre Léon-Bérard, 69008 Lyon, France.

Laura El Nachef (L)

INSERM U1296 unit "Radiation: Defense/Health/Environment" Centre Léon-Bérard, 69008 Lyon, France.

Eymeric Le Reun (E)

INSERM U1296 unit "Radiation: Defense/Health/Environment" Centre Léon-Bérard, 69008 Lyon, France.

Michel Bourguignon (M)

INSERM U1296 unit "Radiation: Defense/Health/Environment" Centre Léon-Bérard, 69008 Lyon, France.
Department of Biophysics and Nuclear Medicine, Université Paris Saclay Versailles St Quentin en Yvelines, 78035 Versailles, France.

Nicolas Foray (N)

INSERM U1296 unit "Radiation: Defense/Health/Environment" Centre Léon-Bérard, 69008 Lyon, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH